Dr. Ashish Goel

Dr. Ashish Goel leads the Value Demonstration team at TCS, focusing on business transformation via evidence generation management and automation. He is a molecular oncologist from Johns Hopkins University, with more than 23 years of experience across different facets of the pharmaceutical industry ranging from new drug discovery to decision support analytics. He has held leadership positions in pharma organizations, assisting in key decisions on designing new chemical entities like Lipaglyn (Zydus), revenue forecasting, and lately real-world evidence and Health Economics and Outcomes Research (HEOR). He has published extensively in peer-reviewed international journals, owns several patents, and has been a speaker at thought leadership forums.